Napredna pretraga

Pregled bibliografske jedinice broj: 971292

Psychopharmacotherapy and dry eye syndrome


Bakija, Ivana; Kaštelan, Snježana; Bogadi, Marija; Pili, Kristijan; Filipčić, Igor
Psychopharmacotherapy and dry eye syndrome // 4th Optometry Conference of Central and South-Eastern Europe in association with European Academy of Optometry and Optics. OCCSEE&EAOO 2018.
Pula, Croatia, 2018. str. 150-150 (poster, međunarodna recenzija, sažetak, znanstveni)


Naslov
Psychopharmacotherapy and dry eye syndrome

Autori
Bakija, Ivana ; Kaštelan, Snježana ; Bogadi, Marija ; Pili, Kristijan ; Filipčić, Igor

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
4th Optometry Conference of Central and South-Eastern Europe in association with European Academy of Optometry and Optics. OCCSEE&EAOO 2018. / - , 2018, 150-150

Skup
4th Optometry Conference of Central and South-Eastern Europe in association with European Academy of Optometry and Optics. OCCSEE&EAOO 2018.

Mjesto i datum
Pula, Croatia, 11-13.05.2018.

Vrsta sudjelovanja
Poster

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
Psychopharmacotherapy, dry eye syndrome

Sažetak
Educational topic Dry eye syndrome (DES) is one of the most common ocular morbidities and often results in significant eye discomfort, visual disturbances and potential damage to the corneal surface. It is a very common eye condition which can be caused by different mechanisms, affects quality of life of large number of population and represents an important and common public health problem. Many systemic drugs have been associated with ocular and visual side effects that require ophthalmological assessment. Furthermore it is known that some drugs used in psychiatry may cause ocular drying through reduction of tear film production. Discussion DES is well-recognized adverse side effect of many topical and systemic medications including psychiatric drugs. In psychiatry, patients with depression, schizophrenia and other psychotic disorders, posttraumatic stress disorders (PTSD) or bipolar disorders who are taking antidepressants, antipsychotics, lithium carbonate and sodium valproate frequently experience dry eye symptoms. Many ocular side effects of psychiatric medications can only be identified with a complete ophthalmological examination which is frequently ignored by psychiatrists during the psychiatric treatment. There is an increasing awareness that incidence of ocular side effects rises rapidly with the use of polypharmacy that is very often seen in psychiatric patients and thus this fact should not be neglected. Conclusions Psychiatrists, ophthalmologists and patients need to be aware and prepared for possible medication-induced adverse effect such as dry eye during the psychiatric treatment. In order to reduce the incidence of side effects of applied medications clinicians should try to use the lowest possible dose to achieve the desired therapeutic effect. Consequently further studies regarding the potential mechanisms of psychiatric medications on the tear film function as well as ocular surface alteration are needed.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Psihijatrijska bolnica "Sveti Ivan" Zagreb